FDA Drug Safety Communication: Drug labels now contain updated recommendations on the appropriate use of long-acting inh
This is a discussion on FDA Drug Safety Communication: Drug labels now contain updated recommendations on the appropriate use of long-acting inh within the FDA News forum, part of the Industry News and Updates category; [06/02/2010]Long-Acting Beta-Agonists (LABAs), a class of medications used for the treatment of asthma and chronic ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-02-2010, 06:43 PM
|
|||
|
|||
FDA Drug Safety Communication: Drug labels now contain updated recommendations on the appropriate use of long-acting inh
[06/02/2010]Long-Acting Beta-Agonists (LABAs), a class of medications used for the treatment of asthma and chronic obstructive pulmonary disease (COPD), now have new recommendations in their drug label intended to promote their safe use in the treatment of asthma.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Drug Safety Communication: Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development | industry_news | FDA News | 0 | 03-31-2010 02:28 PM |
| FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal hea | industry_news | FDA News | 0 | 02-23-2010 12:59 PM |
| FDA Drug Safety Communication: New safety requirements for long-acting inhaled asthma medications called Long-Acting Bet | industry_news | FDA News | 0 | 02-18-2010 01:18 PM |
| U.S. FDA Requests More Safety Data on Long-Acting Beta-Agonists Reuters Health Inform | industry_news | Other Clinical Pharmacy News | 0 | 03-05-2008 05:39 PM |
| FDA updates safety information for long acting beta agonists (LABA). | industry_news | FDA News | 0 | 03-05-2008 04:10 PM |
© 2008 DrugManagementForum™ powered by |
 |